PRQR
ProQR Therapeutics BV
1.70$
+1.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.3% | -12.2% | -5.4% | -5.7% | +45.8% | -5.8% | -1.5% | -9.5% | -22.9% | +1.2% | +17.0% | |
| – | +1.2% | -13.4% | -5.8% | -5.4% | +54.5% | -6.4% | -2.2% | -10.3% | -23.5% | +0.1% | +21.3% | |
| – | +2.9% | -29.5% | -8.6% | +17.9% | +55.1% | -7.5% | -1.7% | -10.7% | -26.4% | +1.1% | +25.3% | |
| – | +2.9% | -15.6% | -7.1% | -3.2% | +55.1% | -7.5% | -1.7% | -10.7% | -26.4% | +1.1% | +25.3% | |
| – | -58.2% | +143.0% | +43.1% | -70.1% | +44.1% | +41.9% | -4.4% | +5.0% | +70.0% | -38.4% | -40.6% | |
| – | – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | +5.2% | -9.8% | -5.1% | +0.1% | -10.0% | -4.4% | +5.4% | -4.5% | -19.9% | +11.7% | -23.6% | |
| – | +33.9% | -1.6% | +7.5% | +10.7% | -8.9% | -9.6% | +6.6% | +0.2% | -16.7% | +24.6% | -13.7% | |
| – | -56.0% | +165.7% | +3.5% | -2.4% | -3.3% | +1.8% | +13.5% | +0.5% | -17.3% | +19.7% | -15.4% | |
| – | +1,274.2% | -79.0% | -90.1% | -2.2% | -52.1% | +2,599.2% | +236.8% | -76.2% | -16.9% | -26.9% | -100.0% | |
| – | +48.5% | – | – | – | – | – | – | – | – | – | – | |
| – | -6.8% | -17.7% | -6.4% | -20.8% | +228.9% | -7.0% | -7.8% | -14.7% | -26.4% | -12.2% | +83.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.1% | +4.0% | +0.1% | +0.0% | +0.0% | +28.9% | +0.0% | +4.5% | -6.4% | +2.3% | +4.4% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.